Axela

Axela

Axela

Our platforms for multiplex nucleic acid or protein analysis are specifically designed to simplify the transition from discovery to diagnostic implementation.
Raised
$2.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$2,847,767
Venture capital (Series A) - 2005
Team Size
10+
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Axela makes some noise.